1. The Efficacy of Psychological Care and Chinese Herbal Decoction in Postoperative Chemotherapy Patients with Endometrial Cancer
    Jinjie Liu et al, 2022, Journal of Healthcare Engineering CrossRef
  2. Emodin derivative E35 and its combination with autophagy inhibitor against acute myeloid leukemia cells in vitro and in vivo
    Li Zhang et al, 2023, Experimental Cell Research CrossRef
  3. Activation and Inhibition of ATM by Phytochemicals: Awakening and Sleeping the Guardian Angel Naturally
    Ammad Ahmad Farooqi et al, 2015, Archivum Immunologiae et Therapiae Experimentalis CrossRef
  4. Rhein augments ATRA-induced differentiation of acute promyelocytic leukemia cells
    Sook-Kyoung Heo et al, 2018, Phytomedicine CrossRef
  5. In Vitro Investigation of the Cytotoxic Activity of Emodin 35 Derivative on Multiple Myeloma Cell Lines
    Jing Zheng et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  6. In Vitro Anticancer Screening and Preliminary Mechanistic Study of A-Ring Substituted Anthraquinone Derivatives
    Ibrahim Morgan et al, 2022, Cells CrossRef
  7. Anthraquinones and Derivatives from Marine-Derived Fungi: Structural Diversity and Selected Biological Activities
    Mireille Fouillaud et al, 2016, Marine Drugs CrossRef
  8. Research Progress and New Perspectives of Anticancer Effects of Emodin
    Wu Liu et al, 2023, The American Journal of Chinese Medicine CrossRef
  9. All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway
    Jingzhi Zhang et al, 2019, Frontiers in Pharmacology CrossRef
  10. Discovery of novel negletein derivatives as potent anticancer agents for acute myeloid leukemia
    Jianlei Wu et al, 2018, Chemical Biology & Drug Design CrossRef
  11. Integration of bioinformatics and experiments to identify TP53 as a potential target in Emodin inhibiting diffuse large B cell lymphoma
    Yanxin Chen et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  12. Dihydromyricetin sensitizes human acute myeloid leukemia cells to retinoic acid-induced myeloid differentiation by activating STAT1
    Ming-hui He et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  13. E35 ablates acute leukemia stem and progenitor cells in vitro and in vivo
    Yingyu Chen et al, 2020, Journal of Cellular Physiology CrossRef
  14. Doxorubicin/Nucleophosmin Binding Protein-Conjugated Nanoparticle Enhances Anti-leukemia Activity in Acute Lymphoblastic Leukemia Cells in vitro and in vivo
    Donghui Gan et al, 2021, Frontiers in Pharmacology CrossRef
  15. The Anti-Leukemic Activity of Natural Compounds
    Coralia Cotoraci et al, 2021, Molecules CrossRef
  16. Association of Platelet Desialylation and Circulating Follicular Helper T Cells in Patients With Thrombocytopenia
    Yuwen Chen et al, 2022, Frontiers in Immunology CrossRef
  17. Design and synthesis of various quinizarin derivatives as potential anticancer agents in acute T lymphoblastic leukemia
    Xiufang Hu et al, 2019, Bioorganic & Medicinal Chemistry CrossRef
  18. miR‑1271‑5p inhibits cell proliferation and induces apoptosis in acute myeloid leukemia by targeting ZIC2
    Xiaohe Chen et al, 2018, Molecular Medicine Reports CrossRef